Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SSX2 Antikörper (C-Term)

Der Kaninchen Polyklonal Anti-SSX2-Antikörper wurde für WB validiert. Er ist geeignet, SSX2 in Proben von Human zu detektieren.
Produktnummer ABIN927674

Kurzübersicht für SSX2 Antikörper (C-Term) (ABIN927674)

Target

Alle SSX2 Antikörper anzeigen
SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))

Reaktivität

  • 49
  • 3
  • 2
Human

Wirt

  • 43
  • 6
Kaninchen

Klonalität

  • 46
  • 3
Polyklonal

Konjugat

  • 21
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser SSX2 Antikörper ist unkonjugiert

Applikation

  • 34
  • 13
  • 13
  • 10
  • 6
  • 5
  • 5
  • 4
  • 3
  • 1
  • 1
Western Blotting (WB)
  • Bindungsspezifität

    • 15
    • 8
    • 6
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    C-Term

    Aufreinigung

    Purified

    Immunogen

    SSX2 antibody was raised in rabbit using the C terminal of SSX2 as the immunogen
  • Applikationshinweise

    WB: 0.2-1 µg/mL
    Optimal conditions should be determined by the investigator.

    Kommentare

    SSX2 Blocking Peptide, (ABIN939235), is also available for use as a blocking control in assays to test for specificity of this SSX2 antibody

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Konzentration

    Lot specific

    Buffer

    Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

    Handhabung

    Avoid repeated freeze/thaw cycles.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
  • Target

    SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))

    Andere Bezeichnung

    SSX2

    Hintergrund

    SSX2 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are probably responsible for transforming activity. Two transcript variants encoding distinct isoforms have been identified for this gene. Synonyms: Polyclonal SSX2 antibody, Anti-SSX2 antibody, synovial sarcoma, X breakpoint 2 antibody, HD21 antibody, HOM-MEL-40 antibody, MGC119055 antibody, MGC15364 antibody, MGC3884 antibody, SSX antibody.
Sie sind hier:
Chat with us!